Opinions
Gerard Ferguson
CannTrust Holdings Inc.
CTST-Q
DON'T BUY
Jul 22, 2019
You find one cockroach, you find others, so there may be more problems involved. Their problems are a warning to the cannabis industry to be more diligent. If any cannabis company's overgrowth winds up on the black market, Health Canada will revoke their license. (He's not saying this is the case with Canntrust.) Selling to medical patients, like Canntrust does, is lucrative.
N/A
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
COMMENT
(opening comment) They raised an amount of cash at their initial offering, so look at the amount of cash per share. Maybe step in near its cash value. You'd be paying nothing for the business. But he doesn't know the specific values and he is only marginally invested in cannabis. There's a risk CTST will lose all its medical customers, so maybe stick closely to the cash value. He owns MediPharm Labs Corp. in this space.
Healthcare